$PAXH
PREAXIA HEALTH CARE PAYMENT SYSTEMS INC.

2021 Q3 Form 10-K Financial Statement

#000126246321000452 Filed on September 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q2
Revenue $41.00 $411.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $39.49K $155.4K $36.28K
YoY Change 17.88% -2.91% -9.86%
% of Gross Profit
Research & Development $2.081K $8.219K $3.140K
YoY Change 54.03% -29.23% -49.11%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $41.57K $163.6K $39.41K
YoY Change 19.27% -4.7% -15.1%
Operating Profit -$41.53K -$163.2K
YoY Change 19.16% -4.94%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$41.53K -$163.2K -$39.41K
YoY Change 19.13% -4.94% -15.1%
Income Tax
% Of Pretax Income
Net Earnings -$41.53K -$163.2K -$39.41K
YoY Change 19.16% -4.94% -15.1%
Net Earnings / Revenue -101297.56% -39706.33%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.098K -$8.255K -$1.994K
COMMON SHARES
Basic Shares Outstanding 19.77M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $40.00 $50.00
YoY Change -100.0% -20.0% -99.72%
Cash & Equivalents $0.00 $46.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $40.00 $46.00
YoY Change -100.0% -20.0% -99.74%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $40.00 $46.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $0.00 $40.00 $46.00
YoY Change -100.0% -20.0% -99.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $624.6K $592.2K $464.7K
YoY Change 27.89% 27.43% 93.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.195M $1.195M $1.195M
YoY Change 0.02% 0.0% 799.35%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.001M $1.960M $1.797M
YoY Change 9.23% 9.08% 6.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.001M $1.960M $1.797M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.001M $1.960M $1.797M
YoY Change 9.23% 9.08% 6.13%
SHAREHOLDERS EQUITY
Retained Earnings -$4.734M -$4.529M
YoY Change
Common Stock $19.77K $19.77K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.001M -$1.960M -$1.797M
YoY Change
Total Liabilities & Shareholders Equity $0.00 $40.00 $46.00
YoY Change -100.0% -20.0% -99.74%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q2
OPERATING ACTIVITIES
Net Income -$41.53K -$163.2K -$39.41K
YoY Change 19.16% -4.94% -15.1%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.109K -$35.72K -$5.870K
YoY Change -18.54% 16.91% -69.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.825K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.069K $35.71K 5.920K
YoY Change -24.03% 182.12% -84.03%
NET CHANGE
Cash From Operating Activities -$9.109K -$35.72K -5.870K
Cash From Investing Activities $0.00 $0.00 0.000
Cash From Financing Activities $9.069K $35.71K 5.920K
Net Change In Cash -$40.00 -$6.00 50.00
YoY Change -105.3% -99.97% -99.72%
FREE CASH FLOW
Cash From Operating Activities -$9.109K -$35.72K -$5.870K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19767698 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
40 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
46 USD
CY2021Q2 us-gaap Assets
Assets
40 USD
CY2020Q2 us-gaap Assets
Assets
46 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163027 USD
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
155551 USD
CY2021Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
429121 USD
CY2020Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
309121 USD
CY2021Q2 paxh Advances Related Party
AdvancesRelatedParty
37696 USD
CY2020Q2 paxh Advances Related Party
AdvancesRelatedParty
9810 USD
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
136465 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
134792 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126967 USD
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1058760 USD
CY2020Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1058760 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1959861 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1796674 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1959861 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1796674 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19767698 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
19768 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
19768 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2655236 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2655236 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
57197 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
57197 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4692022 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
120000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7476 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21115 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35717 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30551 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4528829 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1959821 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1796628 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46 USD
CY2021 us-gaap Revenues
Revenues
411 USD
CY2020 us-gaap Revenues
Revenues
0 USD
CY2021 paxh Consulting Fees
ConsultingFees
120628 USD
CY2020 paxh Consulting Fees
ConsultingFees
126233 USD
CY2021 us-gaap Professional Fees
ProfessionalFees
18160 USD
CY2020 us-gaap Professional Fees
ProfessionalFees
18699 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16597 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15120 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8219 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11614 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
163604 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
171666 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-163193 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-171666 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-163193 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-171666 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19767698 shares
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19726441 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1796628 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-163193 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1959821 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-1674962 USD
CY2020 paxh Issuance Of Shares To Settle Accounts Payable And Accrued Liabilities Related Party Amount
IssuanceOfSharesToSettleAccountsPayableAndAccruedLiabilitiesRelatedPartyAmount
50000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-171666 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-1796628 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-163193 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-171666 USD
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
120000 USD
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
29433 USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
18901 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1547 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9806 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7825 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
3563 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35711 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12658 USD
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6 USD
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17893 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17939 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1959821 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021 paxh Issue Shares To Settle Accounts Payable And Accrued Liabilities Related Party
IssueSharesToSettleAccountsPayableAndAccruedLiabilitiesRelatedParty
0 USD
CY2020 paxh Issue Shares To Settle Accounts Payable And Accrued Liabilities Related Party
IssueSharesToSettleAccountsPayableAndAccruedLiabilitiesRelatedParty
50000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-163193 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35717 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of the Company's consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in these consolidated financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions that our company may undertake in the future, actual results could differ from those estimates.</p>
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8219 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11614 USD
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Tax years 2008 through 2020 are open for examination by taxing authorities
CY2021Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4090000 USD
CY2019Q4 paxh Issue Of Common Stock To Settle Accounts Payable And Accrued Liabilities Related Party Shares
IssueOfCommonStockToSettleAccountsPayableAndAccruedLiabilitiesRelatedPartyShares
100000 shares
CY2019Q4 paxh Issue Of Common Stock To Settle Accounts Payable And Accrued Liabilities Related Party Value
IssueOfCommonStockToSettleAccountsPayableAndAccruedLiabilitiesRelatedPartyValue
50000 USD
CY2021Q2 paxh Advances Related Party
AdvancesRelatedParty
37696 USD
CY2020Q2 paxh Advances Related Party
AdvancesRelatedParty
9810 USD
CY2021Q2 us-gaap Loans Payable Current
LoansPayableCurrent
136465 USD
CY2020Q2 us-gaap Loans Payable Current
LoansPayableCurrent
136465 USD
CY2021 us-gaap Proceeds From Loans
ProceedsFromLoans
0 USD
CY2020 us-gaap Proceeds From Loans
ProceedsFromLoans
3563 USD
CY2021 paxh Repayment Of Loans Payable Shareholder
RepaymentOfLoansPayableShareholder
0 USD
CY2020 paxh Repayment Of Loans Payable Shareholder
RepaymentOfLoansPayableShareholder
0 USD
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
891084 USD
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
882014 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
891084 USD
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
882014 USD
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9070 USD
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
10850 USD
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19767698 shares
CY2019Q4 paxh Issue Of Common Stock To Settle Accounts Payable And Accrued Liabilities Related Party Shares
IssueOfCommonStockToSettleAccountsPayableAndAccruedLiabilitiesRelatedPartyShares
100000 shares
CY2019Q4 paxh Issue Of Common Stock To Settle Accounts Payable And Accrued Liabilities Related Party Value
IssueOfCommonStockToSettleAccountsPayableAndAccruedLiabilitiesRelatedPartyValue
50000 USD

Files In Submission

Name View Source Status
0001262463-21-000452-index-headers.html Edgar Link pending
0001262463-21-000452-index.html Edgar Link pending
0001262463-21-000452.txt Edgar Link pending
0001262463-21-000452-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
paxh-20210531.xsd Edgar Link pending
paxh-20210531_cal.xml Edgar Link unprocessable
paxh-20210531_def.xml Edgar Link unprocessable
paxh-20210531_lab.xml Edgar Link unprocessable
paxh-20210531_pre.xml Edgar Link unprocessable
paxh10k.htm Edgar Link pending
paxh10k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending